SCHEMBL7657327

SCHEMBL7657327

CN(C)C(=O)c1ccc(NC(=O)C(c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 6/20 0.65
KMT2A Q03164 9/20 0.60
MEN1 O00255 6/20 0.60
S1PR3 Q99500 1/20 0.60
CYP3A4 P08684 1/20 0.57
CYP2C9 P11712 1/20 0.57
USP2 O75604 1/20 0.52
ESR1 P03372 1/20 0.52
MAPT P10636 1/20 0.52
NR4A1 P22736 1/20 0.52
PTK2B Q14289 1/20 0.52
NPSR1 Q6W5P4 1/20 0.52
L3MBTL1 Q9Y468 2/20 0.52
ALDH1A1 P00352 4/20 0.51
SMN1; SMN2 Q16637 4/20 0.51
KDM4E B2RXH2 1/20 0.51
BLM P54132 1/20 0.51
HTT P42858 1/20 0.50
RXFP1 Q9HBX9 1/20 0.50
GAA P10253 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7650752 0.84 POLB (0.60) POLBKMT2AMEN1S1PR3CYP3A4
SCHEMBL7651627 0.83 POLB (0.76) POLBKMT2AMEN1S1PR3CYP3A4
SCHEMBL7657652 0.82 POLB (0.76) POLBKMT2AMEN1S1PR3CYP3A4
SCHEMBL1383257 0.80 POLB (1.00) POLBKMT2AMEN1S1PR3CYP3A4
SCHEMBL2842124 0.79 HDAC4 (0.60) KMT2AMEN1CYP3A4CYP2C9USP2
SCHEMBL673385 0.78 HDAC1 (0.69) POLBKMT2AMEN1S1PR3CYP3A4
SCHEMBL15124764 0.77 HTT (0.53) KMT2AL3MBTL1ALDH1A1SMN1; SMN2HTT
SCHEMBL1593422 0.77 MEN1 (0.74) POLBKMT2AMEN1S1PR3MAPT
SCHEMBL23715874 0.76 POLB (0.76) POLBKMT2AMEN1S1PR3CYP3A4
SCHEMBL7655911 0.75 SMN1; SMN2 (0.66) POLBKMT2AMEN1S1PR3MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6407120-B1 ADMINISTERING PYRIDINYLACETAMIDE OR PHENYLACETAMIDE DERIVATIVE TO TREAT CARDIOVASCULAR, EATING, SEXUAL, BRAIN, NERVOUS SYSTEM, GASTROINTESTINAL, UROGENITAL, PSYCHOLOGICAL, AND RESPIRATORY SYSTEM DISORDERS PFIZER INC. 2002-06-18 US disclosed
EP-1033366-A2 Amide derivatives useful as Neuropeptide Y (NPY) antagonists Pfizer Products Inc. (US) 2000-09-06 EP disclosed